Breast Surgery provides a short, up-to-date and practical reference guide for general surgical trainees and established consultants needing a refresher. The seventh edition has been edited and fully revised by respected experts in their fields, and provides a full list of current references and relevant resources. It includes recent developments in breast surgery, including axillary surgery, primary medical therapy, risk reducing surgery, gender affirmation surgery and complications of breast surgery. This volume is part of the Companion to Specialist Surgical Practice series, the pre-eminent reference for trainees in general surgery and those preparing for the FRCS examinations. Each volume summarises key issues within each surgical sub-specialty and provides evidence-based recommendations to support practice. Concise and easy to follow - ideal for exam revision or as a refresher aid Covers all aspects of the topic Fully updated with latest evidence on recent developments, management issues and operative procedures International authorship provides a global perspective Details of relevant investigations and evidence-based recommendations to support practice Key references to support content, plus a comprehensive list of references in the accompanying eBook Links to recommended online videos for further learning New chapter on gender affirmation surgery More information on complications of breast surgery

The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons }Vhy such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of oncology.